You are using an outdated browser. Please upgrade your browser to improve your experience.
TELLAPRIALBI

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection

TELLAPRIALBI

by Howto Health GmbH
TELLAPRIALBI
TELLAPRIALBI
TELLAPRIALBI

What is it about?

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery.

TELLAPRIALBI

App Details

Version
1.3.2
Rating
NA
Size
60Mb
Genre
Medical Education
Last updated
October 29, 2021
Release date
January 7, 2021
More info

App Screenshots

TELLAPRIALBI screenshot-0
TELLAPRIALBI screenshot-1
TELLAPRIALBI screenshot-2
TELLAPRIALBI screenshot-3

App Store Description

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery.

TELLAPRIALBI allows you to
- enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels)
- automatically compute APRI, ALBI and APRI+ALBI scores for comparative review
- select from a variety of tumor types together with the respective extent of resection and
- view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score.

The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app.

TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.